Evidence map›Paper›PMID 34318714›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2021

Evidence for reprogramming of monocytes into reparative alveolar macrophages in vivo by targeting PDE4b.

Ian Rochford, Jagdish Chandra Joshi, Sheikh Rayees, Mumtaz Anwar, Md Zahid Akhter, Lakshmi Yalagala, Somenath Banerjee, Dolly Mehta

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. From development to regeneration: the endothelial interface in lung injury and repair.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Protective effects ofFrontiers in nutrition · 2025
    Article
  10. CLIC4 Regulates Endothelial Barrier Control by Mediating PAR1 Signaling via RhoA.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ian RochfordDepartment of Pharmacology and Regenerative Medicine and Centre for Lung and Vascular Biology, University of Illinois, College of Medicine, Chicago, Illinois.ORCID 0000-0002-1441-6678
Jagdish Chandra JoshiDepartment of Pharmacology and Regenerative Medicine and Centre for Lung and Vascular Biology, University of Illinois, College of Medicine, Chicago, Illinois.
Sheikh RayeesDepartment of Pharmacology and Regenerative Medicine and Centre for Lung and Vascular Biology, University of Illinois, College of Medicine, Chicago, Illinois.
Mumtaz AnwarDepartment of Pharmacology and Regenerative Medicine and Centre for Lung and Vascular Biology, University of Illinois, College of Medicine, Chicago, Illinois.
Md Zahid AkhterDepartment of Pharmacology and Regenerative Medicine and Centre for Lung and Vascular Biology, University of Illinois, College of Medicine, Chicago, Illinois.
Lakshmi YalagalaDepartment of Pharmacology and Regenerative Medicine and Centre for Lung and Vascular Biology, University of Illinois, College of Medicine, Chicago, Illinois.
Somenath BanerjeeDepartment of Pharmacology and Regenerative Medicine and Centre for Lung and Vascular Biology, University of Illinois, College of Medicine, Chicago, Illinois.
Dolly MehtaDepartment of Pharmacology and Regenerative Medicine and Centre for Lung and Vascular Biology, University of Illinois, College of Medicine, Chicago, Illinois.ORCID 0000-0003-0945-9304
University of Illinois Urbana-Champaign · US

Funding

TRPC6 Regulation of Lung Endothelial Barrier FunctionP01HL060678 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2000 to 2020
$40.1M
Trpm2 Regulation of Phagocyte Bactericidal Activity and Resolution of Lung InjuryP01HL077806 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ZHAO, YOU-YANG · 2005 to 2019
$27.0M
TRAINING PROGRAM IN LUNG BIOLOGY AND PATHOBIOLOGYT32HL007829 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOLLY MEHTA · 1995 to 2026
$15.6M
Focal Adhesion Kinase Regulation of Lung Vascular Permeability and EdemagenesisR01HL084153 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MEHTA, DOLLY · 2007 to 2022
$5.4M
HHS | National Institutes of Health (NIH) HL060678HHS | National Institutes of Health (NIH) HL137139HHS | National Institutes of Health (NIH) HL77806HHS | National Institutes of Health (NIH) HL84153NHLBI NIH HHS P01 HL060678NHLBI NIH HHS P01 HL077806NHLBI NIH HHS R01 HL084153NHLBI NIH HHS T32 HL007829
6 · The paper itself

Abstract

Increased lung vascular permeability and neutrophilic inflammation are hallmarks of acute lung injury. Alveolar macrophages (AMϕ), the predominant sentinel cell type in the airspace, die in massive numbers while fending off pathogens. Recent studies indicate that the AMϕ pool is replenished by airspace-recruited monocytes, but the mechanisms instructing the conversion of recruited monocytes into reparative AMϕ remain elusive. Cyclic AMP (cAMP) is a vascular barrier protective and immunosuppressive second messenger in the lung. Here, we subjected mice expressing GFP under the control of the Lysozyme-M promoter (LysM-GFP mice) to the LPS model of rapidly resolving lung injury to address the impact of mechanisms determining cAMP levels in AMϕ and regulation of mobilization of the reparative AMϕ-pool. RNA-seq analysis of flow-sorted Mϕ identified phosphodiesterase 4b (PDE4b) as the top LPS-responsive cAMP-regulating gene. We observed that PDE4b expression markedly increased at the time of peak injury (4 h) and then decreased to below the basal level during the resolution phase (24 h). Activation of transcription factor NFATc2 was required for the transcription of PDE4b in Mϕ. Inhibition of PDE4 activity at the time of peak injury, using intratracheal rolipram, increased cAMP levels, augmented the reparative AMϕ pool, and resolved lung injury. This response was not seen following conditional depletion of monocytes, thus establishing airspace-recruited PDE4b-sensitive monocytes as the source of reparative AMϕ. Interestingly, adoptive transfer of rolipram-educated AMϕ into injured mice resolved lung edema. We propose suppression of PDE4b as an effective approach to promote reparative AMϕ generation from monocytes for lung repair.

Indexed as

Acute Lung InjuryAdoptive TransferAnimalsCapillary PermeabilityCell DifferentiationCyclic AMPCyclic Nucleotide Phosphodiesterases, Type 4FemaleInflammationLipopolysaccharidesMacrophages, AlveolarMaleMiceMice, Inbred C57BLMonocytesNeutrophilsCyclic AMPCyclic Nucleotide Phosphodiesterases, Type 4LipopolysaccharidesNfatc2 protein, mouseNFATC Transcription FactorsPDE4B protein, mousePhosphodiesterase 4 InhibitorsRolipramacute lung injuryalveolar macrophagescAMPmonocytesPDE4b

Identifiers

PMID34318714
PMCPMC8560397
OpenAlexW3184646235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.